100 mg
KLOW
Blend of GHK-Cu, BPC-157, TB-500 and KPV. Studies on the individual components do not evaluate the blend.
For research use only
GHK-Cu
Copper-tripeptide complex studied in collagen synthesis, extracellular matrix activity and skin models.
- Pay by card (Stripe) or Zelle
- Ships within the U.S. with tracking
- Questions? Call or email us
Benefits under study
Research in cells and skin models.
- Collagen synthesis
- Skin matrix remodeling
- Interaction with hyaluronic acid
Research overview
GHK-Cu is a naturally occurring copper complex of the tripeptide glycyl-L-histidyl-L-lysine. First identified in human plasma, it has been studied for decades in dermatological and cell-biology research.
Studies in fibroblast cultures and ex-vivo skin examine its effects on collagen production and extracellular matrix remodeling, including its combination with hyaluronic acid.
Supplied as a 100 mg vial for laboratory research.
Scientific references
Synergy of GHK-Cu and hyaluronic acid on collagen IV upregulation via fibroblast and ex-vivo skin tests
J Cosmet Dermatol, 2023 · PMID 37062921
View on PubMed
You may also need
10 mg · 20 mg · 30 mg · 50 mg
Retatrutide
Investigational peptide targeting GIP, GLP-1 and glucagon receptors. Studied in clinical trials on body weight and glycemic control.
10 mg · 20 mg
Tesamorelin
GHRH analog studied in GH/IGF-1 signaling and visceral fat, including trials in people with HIV and altered fat distribution.